Intratumoral CD8⁺ T-cell differentiation is linked to durable HPV-specific immunity after neoadjuvant HPV vaccination with long-acting IL-7 and PD-1 blockade

Abstract Durable antigen-specific immunity is a goal of therapeutic vaccination, but its relationship to intratumoral CD8⁺ T-cell differentiation remains poorly defined. To address this question, we compared anti–PD-1, tirvalimogene teraplasmid (GX-188E), and long-acting IL-7 (GX-I7/NT-I7), alone and in combination, in HPV-positive tumor-bearing mice. Among tested regimens, triple immunotherapy produced the greatest tumor control and a pooled tumor profile enriched for stemness-associated intratumoral CD8⁺ states. We then evaluated the same components in a four-cohort phase 2 neoadjuvant study of 56 patients with resectable HPV-positive head and neck squamous cell carcinoma. In the 11-patient cohort receiving pembrolizumab, GX-188E, and NT-I7, 7 patients had a major pathologic response, including 4 with a pathologic complete response. To define the intratumoral immune program accompanying this activity, paired tumor profiling identified a GZMK⁺ effector-memory CD8⁺ state with cytotoxicity- and memory-associated features. GZMK⁺ effector-memory cells were prominent among T cells bearing clonotypes shared between post-treatment tumors and tumor-draining lymph nodes, consistent with intercompartmental recirculation. Higher tdLN Myc expression in both NT-I7-containing mouse profiles prompted regulatory analysis of the human GZMK⁺ state, revealing treatment-associated higher MYC and lower BATF regulon specificity; in silico IL7R perturbation was consistent with an IL-7-associated reprogramming model. Post-treatment intratumoral MYC-associated and relative MYC/BATF regulon measures were related to HPV16 E6/E7-reactive activation-induced marker responses at 2 years; in eight patients with paired tumors, treatment-associated relative MYC/BATF changes were separately related to a 2-year peptide-responsive CD8⁺ stem cell–like memory phenotype. Together, these findings associate intratumoral GZMK⁺ effector-memory remodeling with HPV-reactive activation and memory phenotypes 2 years later.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-12
DOI
https://doi.org/10.21203/rs.3.rs-11474333/v1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Intratumoral CD8⁺ T-cell differentiation is linked to durable HPV-specific immunity after neoadjuvant HPV vaccination with long-acting IL-7 and PD-1 blockade

Nam Suk Sim, Min Hee Hong, Eui‐Cheol Shin, Sun Och Yoon et al.
Research Square
Cancer Immunotherapy and Biomarkers
preprint

Intratumoral CD8⁺ T-cell differentiation is linked to durable HPV-specific immunity after neoadjuvant HPV vaccination with long-acting IL-7 and PD-1 blockade

Nam Suk Sim, Min Hee Hong, Eui‐Cheol Shin, Sun Och Yoon, Chang Ho Ahn, Jonathan Gerald Goldin, Hye Ryun Kim, Chang Geol Lee, Jinna Kim, Yoon Woo Koh, Yoon-Jeong Choi, June‐Young Koh, Kyung Hwan Kim, Wonrak Son, Jong-Eun Park, Donghoon Choi, DaHee Kim, Yeju Kim, Seungeun Lee, Su-Hyung Park, Chang Gon Kim, Gamin Kim
preprint en

Abstract

Abstract Durable antigen-specific immunity is a goal of therapeutic vaccination, but its relationship to intratumoral CD8⁺ T-cell differentiation remains poorly defined. To address this question, we compared anti–PD-1, tirvalimogene teraplasmid (GX-188E), and long-acting IL-7 (GX-I7/NT-I7), alone and in combination, in HPV-positive tumor-bearing mice. Among tested regimens, triple immunotherapy produced the greatest tumor control and a pooled tumor profile enriched for stemness-associated intratumoral CD8⁺ states. We then evaluated the same components in a four-cohort phase 2 neoadjuvant study of 56 patients with resectable HPV-positive head and neck squamous cell carcinoma. In the 11-patient cohort receiving pembrolizumab, GX-188E, and NT-I7, 7 patients had a major pathologic response, including 4 with a pathologic complete response. To define the intratumoral immune program accompanying this activity, paired tumor profiling identified a GZMK⁺ effector-memory CD8⁺ state with cytotoxicity- and memory-associated features. GZMK⁺ effector-memory cells were prominent among T cells bearing clonotypes shared between post-treatment tumors and tumor-draining lymph nodes, consistent with intercompartmental recirculation. Higher tdLN Myc expression in both NT-I7-containing mouse profiles prompted regulatory analysis of the human GZMK⁺ state, revealing treatment-associated higher MYC and lower BATF regulon specificity; in silico IL7R perturbation was consistent with an IL-7-associated reprogramming model. Post-treatment intratumoral MYC-associated and relative MYC/BATF regulon measures were related to HPV16 E6/E7-reactive activation-induced marker responses at 2 years; in eight patients with paired tumors, treatment-associated relative MYC/BATF changes were separately related to a 2-year peptide-responsive CD8⁺ stem cell–like memory phenotype. Together, these findings associate intratumoral GZMK⁺ effector-memory remodeling with HPV-reactive activation and memory phenotypes 2 years later.

Research Square
Korea Advanced Institute of Science and Technology (KR), Yonsei University (KR), Severance Hospital (KR), University Health System (US), Gangnam Severance Hospital (KR), Yonsei University Health System (KR), Yonsei Cancer Hospital (KR), NeoImmuneTech, Inc. (United States) (US), Lunit (South Korea) (KR)
National Research Foundation, Yonsei University, Korea Health Industry Development Institute, Ministry of Science and ICT, South Korea, Yonsei University College of Medicine
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon